Table 3 Comparisons between mechanically ventilated GBS patients with good and poor short-term prognoses
Variable | Subgroup 1 (n = 34) | Subgroup 2 (n = 40) | p value |
|---|---|---|---|
Age (years) | 43.9 ± 16.3 | 41.9 ± 17.3 | >0.05 |
Male | 25 (73.5 %) | 23 (57.5 %) | >0.05 |
Antecedent infections | 28 (82.4 %) | 21 (52.5 %) | >0.05 |
Cranial nerve involvement | 26 (76.5 %) | 24 (60 %) | >0.05 |
Facial nerve | 18 (52.9 %) | 22 (55 %) | >0.05 |
Glossopharyngeal and vagus nerves | 18 (52.9 %) | 12 (30 %) | <0.05 |
Sensory disturbance | 16 (47.1 %) | 17 (42.5 %) | >0.05 |
Autonomic dysfunction | 3 (8.8 %) | 2 (5 %) | >0.05 |
Pain | 3 (8.8 %) | 4 (10 %) | >0.05 |
Hyporeflexia or areflexia | 33 (97.1 %) | 39 (97.5 %) | >0.05 |
Hospital stay (days) | 31.0 ± 16.1 | 51.7 ± 31.2 | <0.05 |
Treatment modality | >0.05 | ||
IVIg | 18 (52.9 %) | 15 (37.5 %) | |
IVIg + intravenous corticosteroids | 11 (32.4 %) | 18 (45 %) | |
Intravenous corticosteroids | 2 (5.9 %) | 4 (10 %) | |
Supportive treatment | 3 (8.8 %) | 3 (7.5 %) |